TapestryHealth
PrivateLast Round
Debt
Aug 29, 2023
Total Funding Raised
$25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TapestryHealth operates in Healthcare & Life Sciences and is based in Stratford, Connecticut. Its latest recorded funding round was a Debt round in August 2023.
TapestryHealth is a multi-specialty healthcare company that provides technology-enabled medical services to patients in skilled nursing facilities and other post-acute care environments.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TapestryHealth Comparables
Compare TapestryHealth with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Third Eye Health | 90% | |
| Tembo Health | 85% | |
| Eventus WholeHealth | 83% |
For institutional investors. Book with your work email.
TapestryHealth Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TapestryHealth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sopris Capital | Series A |
| Catalio Capital Management | Debt |
| Sopris Capital Associates | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Brian Foy leaves his CPO role to join Tapestry Health.
- Mar 31, 2026
Brian Foy appointed as the new Chief Product Officer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_issues_withNov 10, 2026
TapestryHealth files for bankruptcy in Connecticut amid a fraud probe after Medicare payments are cut off during an investigation.
- declares_bankruptcyNov 10, 2026
TapestryHealth remains in an ongoing Chapter 11 case in the US Bankruptcy Court for the District of Delaware and faces liquidation without relief from Medicare payment suspensions.
- has_issues_withNov 10, 2026
TapestryHealth argues that the federal government's "groundless" suspension of Medicare payments pushes it to the brink of collapse, prompting bankruptcy filings by the firm and 10 related companies on Nov 10th '26.
For institutional investors. Book with your work email.
TapestryHealth Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TapestryHealth's valuation, stock price, and market status.
Is TapestryHealth a public or private company?
TapestryHealth is a private company.
What is the current stock price of TapestryHealth?
TapestryHealth is a private company, so its shares have no public market price. Caplight tracks TapestryHealth's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TapestryHealth worth (valuation)?
Valuation information for TapestryHealth is not publicly available.
Can I buy TapestryHealth stock?
TapestryHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TapestryHealth's last funding round?
TapestryHealth's most recent funding round was Debt on August 29, 2023.
Who are the main investors in TapestryHealth?
Key investors in TapestryHealth include Sopris Capital, Catalio Capital Management, Sopris Capital Associates.
Will TapestryHealth IPO soon?
No public IPO plans have been announced for TapestryHealth.
How can I track TapestryHealth secondary market activity?
Caplight tracks bids, offers, and trades in TapestryHealth's shares on secondary markets.